MedTrace Logo

Flexible vs. Standard Deep Brain Stimulation Programming in Parkinson Disease Patients

NCT04116177 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-10-10

No results posted yet for this study

Summary

Exploring the benefits of the linear lead in deep brain stimulation.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Deep brain stimulation

Stimulation using VerciseTM system

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04116177 on ClinicalTrials.gov